In spite of the abovementioned shortage, our study is the first to examine the association of CYP2C8 polymorphisms with bladder cancer risk, which may give a new biomarker for the diagnosis or prevention of bladder cancer in the Chinese population. This evidence concerns the gene CYP2C8 and urinary bladder carcinoma.